Bengaluru, India

Umender Kumar Sharma

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Bactoclear Holdings Pte. Ltd. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Umender Kumar Sharma: Innovator in Therapeutic Bacteriocins

Introduction

Umender Kumar Sharma is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of microbiology, particularly through his innovative work on therapeutic bacteriocins. His research focuses on methods and compositions aimed at reducing the growth of microbial colonies, including infections.

Latest Patents

Umender Kumar Sharma holds a patent for his invention titled "Therapeutic Bacteriocins." This patent provides methods and compositions designed to combat microbial growth and infections. It includes therapeutic compositions, methods for treating infections, and techniques for identifying additional compositions that may be effective in this area. He has 1 patent to his name.

Career Highlights

Throughout his career, Umender Kumar Sharma has worked with various companies, including Bactoclear Holdings Pte. Ltd and Ambady, Anisha. His experience in these organizations has contributed to his expertise in developing innovative solutions for microbial infections.

Collaborations

Some of his notable coworkers include Anisha Ambady and Chemira B Appaiah. Their collaboration has likely played a role in advancing his research and patent work.

Conclusion

Umender Kumar Sharma is a distinguished inventor whose work on therapeutic bacteriocins has the potential to significantly impact the treatment of microbial infections. His contributions to the field highlight the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…